Using a two-step process that creates gold nanoparticles that look like kernels of popcorn, researchers at Jackson State University have created a targeted nanoparticle that can detect as few as 50 malignant prostate cells ...
Jan 19, 2011
3.5 / 5 (2)
0
| 
A monoclonal antibody targeting a well known cell surface protein inhibited prostate cancer growth and metastasis in an aggressive form of the disease that did not respond to hormone therapy, according to a study by researchers ...
Nov 08, 2010
5 / 5 (2)
0
|
Diffuse large B-cell lymphoma (DLBCL) is a type of aggressive non-Hodgkin's lymphoma that accounts for approximately 40 percent of lymphomas among adults. If left untreated, it is fatal. The existing treatments have a cure ...
Nov 03, 2010
5 / 5 (2)
0
Even though the cancer-treatment agent cetuximab is not considered effective treatment for KRAS (a gene)-mutated metastatic colorectal tumors, new research indicates that patients with colorectal cancer not responding to ...
Oct 26, 2010
not rated yet
0
A subset of lung cancer patients seem to live longer and experience delays in disease progression when a new drug that targets a cancer-associated molecule called MET is added to treatment with erlotinib, the results of a ...
Oct 09, 2010
not rated yet
0
A new type of breast cancer treatment has shown encouraging activity as a first-line therapy in HER2-positive metastatic disease, researchers reported at the 35th Congress of the European Society for Medical Oncology (ESMO) ...
Oct 08, 2010
5 / 5 (2)
0
Using immunotherapy—biologic agents that stimulate the body’s immune system—pediatric oncologists have achieved the first substantial increase in over a decade in cure rates for the childhood cancer neuroblastoma. A ...
Sep 29, 2010
not rated yet
0
A new disposable device based on advances in microfluidics may help identify advanced breast cancer patients who are candidates for therapy with the drug trastuzumab (Herceptin). The device is described in the American Institute ...
Sep 28, 2010
not rated yet
0
An entirely new type of pharmaceutical substance for Alzheimer’s disease developed by Uppsala scientists is now starting to be clinically tested in the US. It attacks the early stage of the protein filaments that cause ...
Sep 24, 2010
5 / 5 (1)
0
One of the most promising characteristics of nanoparticles as diagnostic agents is the ability to attach to the nanoparticles surface any of a wide variety of targeting molecules that can increase the distinction between ...
Sep 17, 2010
5 / 5 (2)
0
|
A new investigational drug designed to penetrate and attack pancreatic cancer cells has been administered to a patient for the first time ever at the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
Sep 15, 2010
5 / 5 (1)
0
(PhysOrg.com) -- More than half of laboratory mice with human non-Hodgkin's lymphoma are cured by a treatment involving just two monoclonal antibodies, according to a new study.
Sep 02, 2010
not rated yet
0
Neurological and infectious disease experts at Rush University Medical Center are testing a new drug therapy for the treatment of individuals with West Nile fever or suspected central nervous system infection due to the West ...
Aug 18, 2010
not rated yet
0
In a report published in the July 2010 issue of the American Society for Clinical Oncology Post, new recommendations on the use of the drug cetuximab have been issued after officials halted enrollment in a phase III clinic ...
Jul 16, 2010
not rated yet
0
Kidney cancer is a radiographic diagnosis which means treatment decisions are often made based on the findings of a solid mass on CT or MRI. Unfortunately these tests cannot distinguish the different types of kidney cancers ...
Jun 01, 2010
5 / 5 (1)
0
